Portman Ridge Finance Corporation (PTMN)
| Previous close | 19.52 |
| Open | 19.50 |
| Bid | 19.22 x 100 |
| Ask | 19.50 x 100 |
| Day's range | 19.31 - 19.60 |
| 52-week range | 16.27 - 21.12 |
| Volume | |
| Avg. volume | 47,180 |
| Market cap | 180.446M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 11.61 |
| EPS (TTM) | 1.67 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 2.76 (14.23%) |
| Ex-dividend date | 20 May 2024 |
| 1y target est | 20.50 |
Insider MonkeyPortman Ridge Finance Corporation (NASDAQ:PTMN) Q1 2024 Earnings Call Transcript
Portman Ridge Finance Corporation (NASDAQ:PTMN) Q1 2024 Earnings Call Transcript May 9, 2024 Portman Ridge Finance Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Portman Ridge Finance Corporation’s First Quarter 2024 Earnings Conference Call. An earnings press […]
GlobeNewswirePortman Ridge Finance Corporation Announces First Quarter 2024 Financial Results
Reports Net Investment Income of $0.67 Per Share and Net Asset Value of $22.57 Per Share Continued Share Repurchase Program: Total of 51,015 Shares for an Aggregate Cost of Approximately $1.0 Million Repurchased During the First Quarter; Accretive to NAV by $0.02 Per Share Announces Second Quarter 2024 Quarterly Distribution of $0.69 Per Share NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financi
- GlobeNewswire
Portman Ridge Finance Corporation Schedules First Quarter 2024 Earnings Release and Conference Call
Call Scheduled for 9:00 am ET on Thursday, May 9, 2024NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (“Portman Ridge” or the “Company”) to release its financial results for the first quarter ended March 31, 2024, on Wednesday, May 8, 2024, after market close. The Company will host a conference call on Thursday, May 9, 2024, at 9:00 a.m. ET to discuss these results. By Phone: To access the call, please dial (646) 307-1963 approximately 10 minutes pri
